HIV testing: Know, treat, prevent

This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Contact

Sitemap

Links

RSS Feeds

Font:

Accessibility

European Center for Disease Prevention and Control


	Go to extranet



	Advanced Search

You are here: ECDC Portal > English > Health Topics > Health topics in spotlight > Spotlight: HIV testing

PRESENTATIONS

	2010 HIV/AIDS surveillance in Europe, ECDC–WHO/Euro
	HIV testing guidance: know, treat, prevent
	HIV infection and AIDS Surveillance 2009

ESCAIDE PRESENTATIONS

Presentations on HIV infection and AIDS from the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE)

Read presentations

EUROSURVEILLANCE SPECIAL ISSUES

HIV/AIDS and other STI in men who have sex with men (Nov 09)

KNOW MORE ABOUT HIV

The human immunodeficiency virus (HIV) remains one of the most important communicable diseases in Europe. It is an infection associated with serious disease, persistently high costs of treatment and care, significant number of deaths and shortened life expectancy. Read more

HEALTH TOPICS IN SPOTLIGHT

Chlamydia: High numbers, low awareness - Spotlight 2011

Immunisation - Spotlight 2011

New season, different influenza? - Spotlight 2010/11

Surveillance: data for action - Spotlight 2010

Tackling tuberculosis in children: towards a TB-free generation - Spotlight 2011

Tick-borne diseases - Spotlight 2010

Tuberculosis, a global challenge - Spotlight 2010

High numbers & diverse epidemics

Infected but unaware

HIV testing is key

HIV testing: Know, treat, prevent

Key messages

1. HIV infection and AIDS in Europe are characterised by high numbers and diverse epidemics. HIV infection remains of major public health importance in the EU/EEA. In 2010, more than 27 000 newly diagnosed HIV infections were reported across the EU/EEA. Read more

2. Many people in Europe are unaware of their HIV infection. HIV infection can remain asymptomatic for a long period of time, and a high proportion of infected persons are unaware of their affliction. It has been estimated that 30% of individuals infected with HIV in Europe are undiagnosed. Read more

3. HIV testing is essential for prevention, treatment and care. Since the mid 1990s, the benefits of diagnosis and consecutive antiretroviral therapy have been extensively documented. Access to effective therapy has greatly reduced HIV-related morbidity and mortality. Read more

VIDEOS

ECDC TV

EXTERNAL PUBLICATIONS

Policy framework: Scaling up HIV testing and counselling in the WHO European Region as an essential component of efforts to achieve universal access to HIV prevention, treatment, care and support (WHO, 2010)
Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users (EMCDDA, 2010)
Guidance on testing and counselling for HIV in settings attended by people who inject drugs (WHO/UNAIDS, 2009)
European Guideline on HIV Testing (IUSTI- WHO Europe, 2008)
Guidance on provider-initiated HIV testing and counselling in health facilities (WHO/UNAIDS, 2007)

GUIDANCE ON HIV TESTING

This Guidance provides core principles for the development and implementation of national HIV testing strategies. Download here. Also available: In brief

EVIDENCE SYNTHESIS ON HIV TESTING

This review of scientific literature identified evidence for a number of strategies to overcome barriers to HIV testing. Download here

DUBLIN DECLARATION REPORT 2010

This report provides findings from a review of progress made towards its implementation. It is based on data from 49 countries and reflects the contributions of a wide range of individuals and organisations. Download here

HIV SURVEILLANCE REPORT 2009

This report, prepared jointly with the WHO Regional Office for Europe, presents data on HIV and AIDS for the whole European Region, including the EU and EEA countries. Download here